NeuroRx to Take Part in Panel and Present at the Sachs Associates Neuroscience Biopartnering & Investment Forum on March 27th Wilmington, Delaware , March 24, 2017 (GLOBE NEWSWIRE) -- NeuroRx, a clinical stage biopharma company developing the first oral therapy for Acute Suicidal Ideation and Behavior (ASIB), today...

NeuroRx to Present at the Oppenheimer Annual Healthcare Conference on March 21st Wilmington, Delaware , March 20, 2017 (GLOBE NEWSWIRE) -- NeuroRx, a clinical stage biopharma company developing the first oral therapy for Acute Suicidal Ideation and Behavior (ASIB), today...

NeuroRx to Present at the BIO CEO & Investor Conference on February 13 Wilmington, Delaware & Tel Aviv, Israel , Feb. 10, 2017 (GLOBE NEWSWIRE) -- NeuroRx, a clinical stage biopharma company developing the first oral therapy for Acute Suicidal Ideation and...